Obamacare Subsidies Upheld by U.S. Supreme Court (UNH) (HCA) (CYH)

Leerink Partners Raises Price Target on Community Health (CYH) Following Favorable SCOTUS Ruling

Leerink Partners reiterates an Outperform rating on Community Health (NYSE: CYH), and raised the price target to $70.00 (from $60.00), following a favorable Supreme Court ruling yesterday.

Analyst Ana Gupte commented, "SCOTUS ruled yesterday on King v. Burwell in favor of the... More

Leerink Partners Raises Price Target on Tenet Healthcare (THC) Following Supreme Court Ruling

Leerink Partners maintain a Market Perform rating on Tenet Healthcare (NYSE: THC), and raised the price target to $60.00 (from $56.00), following a favorable Supreme Court ruling yesterday.

Analyst Ana Gupte commented, "SCOTUS ruled yesterday on King v. Burwell in favor of the... More

Raymond James Downgrades Community Health (CYH) to Market Perform

Raymond James downgraded Community Health (NYSE: CYH) from Outperform to Market Perform and removed its price target (prior $56.00).

For an analyst ratings summary and ratings history on Community Health click here. For more ratings news on Community Health click here.

Shares of Community Health closed at $62.45 yesterday.

Wells Fargo Upgrades Tenet Healthcare (THC) to Outperform

Wells Fargo upgraded Tenet Healthcare (NYSE: THC) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $56.21 yesterday.

Wells Fargo Upgrades Community Health (CYH) to Outperform

Wells Fargo upgraded Community Health (NYSE: CYH) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Community Health click here. For more ratings news on Community Health click here.

Shares of Community Health closed at $62.45 yesterday.

Mizuho Securities Upgrades Community Health (CYH) to Outperform

Mizuho Securities upgraded Community Health (NYSE: CYH) from Neutral to Outperform with a price target of $83.90 following the SCOTUS decision.

"In the wake of the 6-3 strong decision yesterday that likely limits further ACA challenges and supports continued enrollment growth in exchange... More